WO1991012721A1 - Disinfectant - Google Patents

Disinfectant Download PDF

Info

Publication number
WO1991012721A1
WO1991012721A1 PCT/GB1991/000240 GB9100240W WO9112721A1 WO 1991012721 A1 WO1991012721 A1 WO 1991012721A1 GB 9100240 W GB9100240 W GB 9100240W WO 9112721 A1 WO9112721 A1 WO 9112721A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
composition according
skin
disinfectant
surfactant
Prior art date
Application number
PCT/GB1991/000240
Other languages
French (fr)
Inventor
Bernard Patrick Bradley
Original Assignee
Hill, Kenneth, John
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hill, Kenneth, John filed Critical Hill, Kenneth, John
Publication of WO1991012721A1 publication Critical patent/WO1991012721A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12Iodine, e.g. iodophors; Compounds thereof

Definitions

  • the present invention relates to a bacteriocidal and viricidal disinfectant composition suitable for application to the skin and particularly but not exclusively, for use in hospitals as a pre-operative scrub or for use in emergency situations.
  • Disinfectant compositions have been known for many years and their principal objective has been the killing of bacteria.
  • the disinfectant products used at present in industry are generally selected on the basis of their bacteriocidal properties. However, these products are sometimes inadequate to deal with viruses, which may be more difficult to kill effectively.
  • More recently, a number of pathological viruses have evolved, the most notable being the human immunodefficiency virus (HIV) which is responsible for acquired immunodefficiency syndrome (AIDS) .
  • HIV human immunodefficiency virus
  • AIDS acquired immunodefficiency syndrome
  • ⁇ - ere is the potential for such viruses to be transmitted by skin contact, and there is a danger of infection where open wounds are present. For example, a policeman or ambulanceman who sustains an open wound in dealing with a drug addict or other person having a high probability of HIV infection, requires a quick and convenient disinfectant composition which can be used immediately.
  • compositions comprising 2-phenox ethanol and complexed iodine as active agents are known in the prior art. However, a number of such formulations have been found to stain the skin, which is generally undesirable, particularly where the composition is to be used repeatedly as, for example, a pre-operative scrub.
  • the disinfectant composition may require to be used in emergency situations where the skin or wound is dirty, it is desirable that the disinfectant composition should include a surfactant, so that it is capable of cleaning and disinfecting in one operation.
  • the present invention provides a bacteriocidal and viricidal disinfectant composition suitable for application to the skin, which comprises
  • the present disinfectant composition is bacteriocidally effective against gram positive and gram negative bacteria. It will also kill viruses such as HIV and Herpes Simplex on the surface of the skin.
  • a number of complexed iodine formulations are known in the art, such as polyvinylpyrrolidone-iodine complexes and other iodophors.
  • the present invention envisages the use of any of these in appropriate proportions.
  • the iodine complex generally imparts a brown colour to the disinfectant composition, which allows the areas of the skin being cleansed by the composition to be monitored visually so as to ensure complete coverage. Despite this brown colouration, the composition has been found to be non-staining - possibly due to the presence of the surfactant.
  • the surfactant is one which is compatable with the active disinfecting agents and imparts cleansing properties to the composition.
  • the anionic surfactant is generally a long chain sulphate or sulphonate, including alcohol sulphates, and commercially available surfactants generally include a mixture of such compounds.
  • the surfactant might also be an amphoteric surfactant, such as CoCo amido betaine which can exist in either anionic or cationic forms depending on pH.
  • the vegetable oil diethanolamide may be based on any of the available natural oils, such as coconut oil. The function is to provide a surfactant and emolient, which renders the composition viscous and compatible with the skin.
  • the disinfectant composition is provided in the form of a skin cream which is applied undiluted and may be washed off after use. This facilitates use in.emergency situations.
  • the viscosity is in the range 180-275 cS as determined on a Brookfield viscometer.
  • the pH of the composition is less than 6.5, preferably in the range 5.5 to 6.0 or as low as 2.5 to 3.0.
  • the active disinfectant agents are only effective under acid conditions, although the use of very acidic compositions is to be avoided as causing skin damage.
  • composition may also contain additional emolients, such as glycerine or lanolin, usually in an amount 1.0 to 2.0 weight %.
  • Glycerine is to be preferred since it is substantially non-allergenic.
  • composition may include formulation adjuncts necessary to provide a stable and partially clarified composition, such as isopropyl alcohol. This prevents phase separation, clarifies the composition to a degree, and additionally acts as a germicide in its own right.
  • formulation adjuncts necessary to provide a stable and partially clarified composition, such as isopropyl alcohol. This prevents phase separation, clarifies the composition to a degree, and additionally acts as a germicide in its own right.
  • the composition is. preferably in the form of a skin cream which is conveniently used undiluted.
  • the composition may be provided in multidose containers equipped with dispensing means, or may be provided in discreet dosage packages such as sachets, usually containing 2-10ml, preferably 3-5ml.
  • the effective viricidal properties of the disinfectant composition make it particularly useful in emergency situations where HIV virus may be encountered and also provide a pre-operative scrub which is generally more effective than those used at present (such as those based on parachloro etaxylenols) .
  • the composition also finds general use in hospitals for routine hand disinfectant by doctors and nurses to avoid transmission of micro-organisms, which can survive for prolonged periods on the skin.
  • many instances of food poisoning could be prevented by careful hand disinfection. It is generally recognised that hygenic hand washing in the xoodstuff industry is a major factor in controlling the spread of harmful bacteria.
  • the prevention of contamination by bacteria from human sources is an integral part of good manufacturing practise in the production and processing of toiletries, cosmetics and pharmaceuticals.
  • Example 1 (Anionic Surfactant)
  • a disinfectant composition according to the invention was made up from the following:
  • a further disinfectant composition according to the invention was made up as follows: (3.8 wt%) 2-phenoxyethanol (1% available iodine) iodine - polyvinylpyrrolidone complex. 50 1 (16 wt%) CoCo amido betaine
  • the CoCo-a ido betaine was mixed with the coconut oil diethanolamide and the remainder of the water, and mixed for one hour.
  • the pH of the second mixture was adjusted to pH 2.5 to 3.0 with the citric acid.
  • the two mixtures were then mixed together and mixing continued for one hour.
  • the product is useful as a surgical scrub.
  • the amphoteric surfactant CoCo-amido betaine is available from Sandor Chemicals, Leeds, UK under the tradename SANDOTERIC SC.
  • the iodine-polyvinylpyrrolidone complex is available from BASF.
  • Example 1 The composition prepared in Example 1 was tested for viricidal activity as follows.
  • the disinfectant used neat inactivated 1 ml of HIV mixture which had been put on the shaved surface of rodent skin (5 x 5 cm 2 ) at both 0.5 and 1 min contact times at 20°C. No residual virus infectivity was recovered by washing the outer surface of the skin with 5 ml of tissue culture medium and assaying for infectivity.
  • the disinfectant(used neat) inactivated 10 8 pfu/ml of Herpes Simplex virus at both 0.5 and 1 min contact times at 20°C when residual infectivity was titrated in human fibroblast cells (MRC-5 cells).
  • MRC-5 cells human fibroblast cells
  • the HSV in 90% serum was diluted in 10-fold steps to 10" 6 and aliquots of each dilution were then plated onto monolayers of MRC-5 cells. After 3 days culture at 37°C the end point dilution of the HSV infectivity was read. The results show removal of viral infectivity.
  • Example 1 The killing capabilities of the composition of Example 1 was assessed against a variety of micro-organisms. To simulate conditions of use where body fluids would provide Organic matter 7 likely to inhibit product activity, a series of tests were conducted in the presence of serum at body temperature. In each case the concentration of organisms killed in the test suspensions was between 1 and 5 million per ml. These tests were performed at 37°C. The results are given in Table 1.
  • this formulation still has a 9-fold higher concentration of available iodine than is required to kill a million Pseudomonas per ml in the presence of 10% serum at 37°C.
  • the excess concentration is 18-fold greater than required for the strains of E-coli. Staph aureus and Acinetobacter calcoaceticus.
  • the figures are significant in view of the fact that these organisms are serious hospital pathogens and Acinetobacter is a very troublesome pathogen in burns units, the strains currently carrying resistance to a wide range of antibiotics in common use and present great difficulties of eradication.
  • the disinfectant would clearly be able to play a useful role in the prevention of sepsis, and the subsequent morbidity and deaths which result from infection with organisms listed above.
  • the disinfectant composition was found to be substantially non-staining, possibly due to the presence of the surfactant.

Abstract

A bacteriocidal and viricidal disinfectant composition suitable for application to the skin comprises (a) 2.3 to 4.0 wt % 2-phenoxyethanol; (b) 0.8 to 1.8 wt % complexed iodine; (c) 5.0 to 20.0 wt % anionic or amphoteric surfactant; (d) 1.5 to 6.0 wt % vegetable oil diethanolamide; the balance being water; and the pH of the composition being less than 6.5. Preferably, it is in the form of a viscous skin cream containing suitable emollients.

Description

DISINFECTANT
The present invention relates to a bacteriocidal and viricidal disinfectant composition suitable for application to the skin and particularly but not exclusively, for use in hospitals as a pre-operative scrub or for use in emergency situations.
Disinfectant compositions have been known for many years and their principal objective has been the killing of bacteria. The disinfectant products used at present in industry are generally selected on the basis of their bacteriocidal properties. However, these products are sometimes inadequate to deal with viruses, which may be more difficult to kill effectively. More recently, a number of pathological viruses have evolved, the most notable being the human immunodefficiency virus (HIV) which is responsible for acquired immunodefficiency syndrome (AIDS) . ϊ- ere is the potential for such viruses to be transmitted by skin contact, and there is a danger of infection where open wounds are present. For example, a policeman or ambulanceman who sustains an open wound in dealing with a drug addict or other person having a high probability of HIV infection, requires a quick and convenient disinfectant composition which can be used immediately.
Similarly, there is a need in hospitals for a pre-operative scrub for surgeons and nurses which has maximum efficiency in killing viruses and bacteria, but which is topically acceptable so that the hands do not become sore with repeated use.
Compositions comprising 2-phenox ethanol and complexed iodine as active agents are known in the prior art. However, a number of such formulations have been found to stain the skin, which is generally undesirable, particularly where the composition is to be used repeatedly as, for example, a pre-operative scrub.
Finally, since the disinfectant composition may require to be used in emergency situations where the skin or wound is dirty, it is desirable that the disinfectant composition should include a surfactant, so that it is capable of cleaning and disinfecting in one operation.
It is therefore an object of the present invention to provide a bacteriocidal and viricidal disinfectant composition suitable for application to the skin which additionally incorporates a surfactant for cleansing.
The present invention provides a bacteriocidal and viricidal disinfectant composition suitable for application to the skin, which comprises
(a) 2.3 to 4.0 (preferably 2.3 to 3.5) weight % 2-phenoxyethanol
(b) 0.8 to 1.8 (preferably 1.0 to 1.8) weight % complexed iodine
(c) 5.0 to 20.0 weight % anionic or amphoteric surfactant
(d) 1.5 to 6.0 (preferably 1.5'to 3.0) weight % vegetable oil diethanolamide; the balance being water; and the pH of the composition being less than 6.5.
The present disinfectant composition is bacteriocidally effective against gram positive and gram negative bacteria. It will also kill viruses such as HIV and Herpes Simplex on the surface of the skin.
■ A number of complexed iodine formulations are known in the art, such as polyvinylpyrrolidone-iodine complexes and other iodophors. The present invention envisages the use of any of these in appropriate proportions. The iodine complex generally imparts a brown colour to the disinfectant composition, which allows the areas of the skin being cleansed by the composition to be monitored visually so as to ensure complete coverage. Despite this brown colouration, the composition has been found to be non-staining - possibly due to the presence of the surfactant.
The surfactant is one which is compatable with the active disinfecting agents and imparts cleansing properties to the composition. The anionic surfactant is generally a long chain sulphate or sulphonate, including alcohol sulphates, and commercially available surfactants generally include a mixture of such compounds. The surfactant might also be an amphoteric surfactant, such as CoCo amido betaine which can exist in either anionic or cationic forms depending on pH. The vegetable oil diethanolamide may be based on any of the available natural oils, such as coconut oil. The function is to provide a surfactant and emolient, which renders the composition viscous and compatible with the skin. Preferably, the disinfectant composition is provided in the form of a skin cream which is applied undiluted and may be washed off after use. This facilitates use in.emergency situations. Generally the viscosity is in the range 180-275 cS as determined on a Brookfield viscometer.
The pH of the composition is less than 6.5, preferably in the range 5.5 to 6.0 or as low as 2.5 to 3.0. The active disinfectant agents are only effective under acid conditions, although the use of very acidic compositions is to be avoided as causing skin damage.
The composition may also contain additional emolients, such as glycerine or lanolin, usually in an amount 1.0 to 2.0 weight %. Glycerine is to be preferred since it is substantially non-allergenic.
Additionally, the composition may include formulation adjuncts necessary to provide a stable and partially clarified composition, such as isopropyl alcohol. This prevents phase separation, clarifies the composition to a degree, and additionally acts as a germicide in its own right.
As mentioned above, the composition is. preferably in the form of a skin cream which is conveniently used undiluted. The composition may be provided in multidose containers equipped with dispensing means, or may be provided in discreet dosage packages such as sachets, usually containing 2-10ml, preferably 3-5ml.
The effective viricidal properties of the disinfectant composition make it particularly useful in emergency situations where HIV virus may be encountered and also provide a pre-operative scrub which is generally more effective than those used at present (such as those based on parachloro etaxylenols) . The composition also finds general use in hospitals for routine hand disinfectant by doctors and nurses to avoid transmission of micro-organisms, which can survive for prolonged periods on the skin. In the food industry, many instances of food poisoning could be prevented by careful hand disinfection. It is generally recognised that hygenic hand washing in the xoodstuff industry is a major factor in controlling the spread of harmful bacteria. In the cosmetics and pharmaceuticals industry, the prevention of contamination by bacteria from human sources is an integral part of good manufacturing practise in the production and processing of toiletries, cosmetics and pharmaceuticals.
Embodiments of the present invention will now be described by way of example only. Example 1 (Anionic Surfactant)
A disinfectant composition according to the invention was made up from the following:
2.5 weight % 2-phenoxyethanol
1.2 weight % iodine - polyvinylpyrrolidone complex
30.0 weight % lauryl ether sulphate (3 mole)
(27% pure = 8.1% active).
1.5 weight* % glycerine B.P. - ~
1.5 weight % coconut oil diethanolamide
2.0 weight % isopropyl alcohol
61.3 weight % water total volume equals 1,000 ml.
500ml of water were placed in a mixing vessel and heated to 60°C. The lauryl ether sulphate was mixed with the coconut oil diethanolamide and the mixture heated to 60°C, before being added to the water and cooled to 20°C. The pH was adjusted to 2.5 - 3 using 50% citric acid solution. The glycerine and isopropyl alcohol were mixed together before being added to the previous mixture. Mixing was carried out for 10 minutes before addition of the 2-phenoxyethanol and the iodine. Further mixing was carried out for one hour and the balance of the water added to bring the volume up to 1,000ml.
Example 2 (Amphoteric Surfactant)
A further disinfectant composition according to the invention was made up as follows: (3.8 wt%) 2-phenoxyethanol
Figure imgf000009_0001
(1% available iodine) iodine - polyvinylpyrrolidone complex. 50 1 (16 wt%) CoCo amido betaine
(60% active solution) 10 1 (5 wt%) coconut oil diethanolamide 1.6 1 (0.8 wt%) citric acid (50% solution) 120 1 (balance) water total volume equals 200 litres
Half of the volume of water was placed in a vessel and the iodine-polyvinylpyrrolidene complex was added under high shear conditions and mixing was effected for one hour. The 2-phenoxyethanol was then added and further mixing carried out for 30 mins.
In a separate vessel, the CoCo-a ido betaine was mixed with the coconut oil diethanolamide and the remainder of the water, and mixed for one hour. The pH of the second mixture was adjusted to pH 2.5 to 3.0 with the citric acid. The two mixtures were then mixed together and mixing continued for one hour. The product is useful as a surgical scrub.
The amphoteric surfactant CoCo-amido betaine is available from Sandor Chemicals, Leeds, UK under the tradename SANDOTERIC SC. the iodine-polyvinylpyrrolidone complex is available from BASF. Example 3 - viricidal Activity
The composition prepared in Example 1 was tested for viricidal activity as follows.
The disinfectant (used neat) inactivated 1 ml of HIV mixture which had been put on the shaved surface of rodent skin (5 x 5 cm2) at both 0.5 and 1 min contact times at 20°C. No residual virus infectivity was recovered by washing the outer surface of the skin with 5 ml of tissue culture medium and assaying for infectivity.
The disinfectant(used neat) (i.e. final concentration 1/2) inactivated 108 pfu/ml of Herpes Simplex virus at both 0.5 and 1 min contact times at 20°C when residual infectivity was titrated in human fibroblast cells (MRC-5 cells). For this test series, at the end of the contact times the HSV in 90% serum was diluted in 10-fold steps to 10"6 and aliquots of each dilution were then plated onto monolayers of MRC-5 cells. After 3 days culture at 37°C the end point dilution of the HSV infectivity was read. The results show removal of viral infectivity.
Example 4 (Bacteriocidal Action)
The killing capabilities of the composition of Example 1 was assessed against a variety of micro-organisms. To simulate conditions of use where body fluids would provide Organic matter7 likely to inhibit product activity, a series of tests were conducted in the presence of serum at body temperature. In each case the concentration of organisms killed in the test suspensions was between 1 and 5 million per ml. These tests were performed at 37°C. The results are given in Table 1.
Table 1 Germicidal effect in the presence of 10% serum at 7°-C. Contact Time 1 minute
E. coli NCTC 10418 5.63% v/v
Staph. aureus NCTC 6571 5.63% v/v
Pseudomonas aeruginosa MUCOB 237 11.25% v/v Acinetobacter calcoaceticus 73099 5.63% v/v Salmonella paratyphi B MUCOB 211 2.82% v/v Klebsiella edwardsii var atlantae 2.82% v/v Proteus vulgaris MUCOB 364 2.82% v/v The tests we have performed show that the disinfectant is a highly active germicide even in the presence of relatively high concentrations of serum (10%) . The most resistant organism in these tests was Pseudomonas aeruσinosa which is a common finding where anti-bacterial tests are undertaken with antiseptics and disinfectants. However, this formulation still has a 9-fold higher concentration of available iodine than is required to kill a million Pseudomonas per ml in the presence of 10% serum at 37°C. The excess concentration is 18-fold greater than required for the strains of E-coli. Staph aureus and Acinetobacter calcoaceticus. The figures are significant in view of the fact that these organisms are serious hospital pathogens and Acinetobacter is a very troublesome pathogen in burns units, the strains currently carrying resistance to a wide range of antibiotics in common use and present great difficulties of eradication. The disinfectant would clearly be able to play a useful role in the prevention of sepsis, and the subsequent morbidity and deaths which result from infection with organisms listed above.
In these tests, the disinfectant composition was found to be substantially non-staining, possibly due to the presence of the surfactant.
Example 5 - Skin Compatibility
Skin compatibility tests were carried out by applying the composition to 5 cm2 areas of skin on 30 patients at The Royal Infirmary, Glasgow. The patients were those suffering from a variety of skin complaints. No patient showed any allergic reaction to the composition of the invention. Two (only) of the patients reported a slight staining effect.

Claims

CIAIMS
1) A bacteriocidal and viricidal disinfectant composition suitable for application to the skin which comprises
(a) 2.3 to 4.0 wt % 2-phenoxyethanol;
(b) 0.8 to 1.8 wt % complexed iodine;
(c) 5.0 to 20.0 wt % anionic or amphoteric surfactant;
(d) 1.5 to 6.0 wt % vegetable oil diethanolamide; the balance being water; and the pH of the composition being less than 6.5.
2) A composition according to claim 1 having an elevated viscosity such that the composition is suitable for use as a skin cream.
3) A composition according to claim 2 wherein the viscosity is in the region 180-275 cS.
4) A composition according to claim 1 which further comprises glycerine.
5) A composition according to claim 1 which further comprises isopropyl alcohol.
6) A composition according to claim 1 having a pH of 5.5 to 6.0. 7) A composition according to claim 1 which comprises 2.3 to 4.0 wt % 2-phenoxyethanol.
8) A composition according to claim 1 wherein the surfactant is an anionic surfactant.
9) A composition according to claim 1 wherein the surfactant is an amphoteric surfactant.
10) A composition according to claim 1 comprising 1.5 to 3.0 wt % vegetable oil diethanolamide.
11) A composition according to claim 1 comprising 1.0 to 1.8 wt % complexed iodine.
PCT/GB1991/000240 1990-02-20 1991-02-18 Disinfectant WO1991012721A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909003787A GB9003787D0 (en) 1990-02-20 1990-02-20 Disinfectant
GB9003787.0 1990-02-20

Publications (1)

Publication Number Publication Date
WO1991012721A1 true WO1991012721A1 (en) 1991-09-05

Family

ID=10671292

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1991/000240 WO1991012721A1 (en) 1990-02-20 1991-02-18 Disinfectant

Country Status (3)

Country Link
GB (1) GB9003787D0 (en)
WO (1) WO1991012721A1 (en)
ZA (1) ZA907620B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0582360A1 (en) * 1992-07-31 1994-02-09 SCHÜLKE & MAYR GMBH Disinfecting agent based carboxylic acids
WO1999043209A1 (en) * 1998-02-27 1999-09-02 Buckman Laboratories International, Inc. Potentiation of biocide activity using a diethanolamide
EP1134279A1 (en) * 2000-03-14 2001-09-19 Bode Chemie GmbH & Co. Antimicrobial active substance combinations
WO2009056322A2 (en) * 2007-10-31 2009-05-07 Mundipharma International Limited Foam stabilizer for a sterilization composition

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2110424A1 (en) * 1970-10-14 1972-06-02 Richardson Merrell Ltd Antibacterial cleansing lotion - contg bis-phenols and phenoxyalkanols as bactericides
US4057648A (en) * 1970-05-16 1977-11-08 Ciba-Geigy Corporation Compositions for the control of microorganisms
WO1986005359A1 (en) * 1985-03-13 1986-09-25 Gluck Bruno A Antiseptic compositions
EP0231080A1 (en) * 1986-01-16 1987-08-05 Imperial Chemical Industries Plc Antiseptic compositions
EP0259249A2 (en) * 1986-07-23 1988-03-09 Ciba-Geigy Ag Microbicidal preparations
GB2204054A (en) * 1987-04-30 1988-11-02 Neutrogena Corp Antibacterial soap base composition and method of making same

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057648A (en) * 1970-05-16 1977-11-08 Ciba-Geigy Corporation Compositions for the control of microorganisms
FR2110424A1 (en) * 1970-10-14 1972-06-02 Richardson Merrell Ltd Antibacterial cleansing lotion - contg bis-phenols and phenoxyalkanols as bactericides
WO1986005359A1 (en) * 1985-03-13 1986-09-25 Gluck Bruno A Antiseptic compositions
EP0231080A1 (en) * 1986-01-16 1987-08-05 Imperial Chemical Industries Plc Antiseptic compositions
EP0259249A2 (en) * 1986-07-23 1988-03-09 Ciba-Geigy Ag Microbicidal preparations
GB2204054A (en) * 1987-04-30 1988-11-02 Neutrogena Corp Antibacterial soap base composition and method of making same

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0582360A1 (en) * 1992-07-31 1994-02-09 SCHÜLKE & MAYR GMBH Disinfecting agent based carboxylic acids
WO1999043209A1 (en) * 1998-02-27 1999-09-02 Buckman Laboratories International, Inc. Potentiation of biocide activity using a diethanolamide
US6235299B1 (en) 1998-02-27 2001-05-22 Buckman Laboratories International Inc Potentiation of biocide activity using diethanolamide
US6413531B2 (en) 1998-02-27 2002-07-02 Buckman Laboratories International, Inc. Potentiation of biocide activity using a diethanolamide
EP1134279A1 (en) * 2000-03-14 2001-09-19 Bode Chemie GmbH & Co. Antimicrobial active substance combinations
WO2009056322A2 (en) * 2007-10-31 2009-05-07 Mundipharma International Limited Foam stabilizer for a sterilization composition
WO2009056322A3 (en) * 2007-10-31 2009-07-30 Mundipharma Internat Ltd Foam stabilizer for a sterilization composition
US20100239519A1 (en) * 2007-10-31 2010-09-23 Mundipharma International Limited Foam Stabilizer Composition
CN101951762A (en) * 2007-10-31 2011-01-19 萌蒂医药国际有限公司 The foam stabiliser that is used for sterilization composition
KR101204782B1 (en) * 2007-10-31 2012-11-26 문다이팔마 인터내셔널 리미티드 Foam stabilizer for a sterilization composition
EA018134B1 (en) * 2007-10-31 2013-05-30 Мандифарма Интернэшнл Лимитед Composition for sterilization

Also Published As

Publication number Publication date
GB9003787D0 (en) 1990-04-18
ZA907620B (en) 1991-07-31

Similar Documents

Publication Publication Date Title
AU2002322916B2 (en) A wide spectrum disinfectant
US20090035339A1 (en) Methods of Inactivating Viruses
JP2006519841A (en) Surface disinfecting composition with improved antibacterial performance
US5244666A (en) Presurgical skin scrub and disinfectant
CA2406558A1 (en) Antimicrobial composition formulated with essential oils
MX2013008801A (en) Antimicrobial composition.
Laufman Current use of skin and wound cleansers and antiseptics
Walker Quaternary ammonium compounds
US3052604A (en) Germicidal composition
EP0609106A1 (en) A glutaraldehyde composition
WO1991012721A1 (en) Disinfectant
US6441045B1 (en) Disinfectant composition
CA2436808C (en) Liquid antimicrobial compositions
AU2002217319A1 (en) Liquid antimicrobial compositions
US20020045666A1 (en) Disinfecting preparation containing chlorine in alcohol
JPS6357502A (en) Antiseptic composition for finger
RU2125467C1 (en) Disinfectant agent "veltosept"
WO2001047534A1 (en) Non-staining topical iodine composition
AU2007237333B2 (en) A wide spectrum disinfectant
Alsaedy et al. Production and investigation of a new effective and safe hand antiseptic
Paulson Topical antimicrobials: classification and performance
Scott et al. The comparative value of metaphen in alcohol-acetone-aqueous solutions in the pre-operative disinfection of the skin
Fahad et al. Preparation and studying of the physiochemical properties and antimicrobial activity of new triple-action glass cleaners
RU2187337C1 (en) Disinfecting agent "veltoks"
CN114948774A (en) Disinfecting hand sanitizer with coexistence of anions and cations and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): GB US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE